·|û°Ñ¥[¡u104¦~·|û¤j·|º[¾Ç³NºtÁ¿·|¡v¡A½Ð«ù¡u¨¥÷ÃÒ¡v¿Ë¦Ûu¥x¤jÂå°|°ê»Ú·|ij¤¤¤ß¤G¼Ó¤jÆU(¥x¥_¥«®}¦{¸ô2¸¹)¦~·|³ø¨ì³B¡A¥i¨³³t¿ì²z³ø¨ì¤âÄò¡C¤]¥i«ù¶K¦³·Ó¤ù¤§¨ä¥LÃÒ©ú¤å¥ó¿ì²z³ø¨ì¡A§¹¦¨³ø¨ìµ{§ÇªÌ¡A¥iÀò¥»·|Ä~Äò±Ð¨|¿n¤À¢ÏÃþ30¤À¡C
ÃB¥~»{©w¤§¢ÐÃþ¡B¢ÑÃþ¡B¿}§¿¯f¦@¦P·ÓÅ@ºô±Ð¨|¾Ç¤À¡A»Ý¦ÜºtÁ¿Á¿°óªù¤f³ø¨ì¡C
¸Ô²Ó»¡©ú¦p¤U¡G
AÃþ±Ð¨|¾Ç¤À30¤À¡G
- ³ø¨ì¤è¦¡¡G½Ð·|û¥»¤H«ù¡u¨¥÷ÃÒ¡v¡A©Î¶K¦³·Ó¤ù¤§ÃÒ©ú¤å¥ó¿Ë¦Û³ø¨ì¡C
- ³ø¨ì®É¶¡¡G104¦~12¤ë5¤é¦Ü6¤é¡F¨C¤é¤W¤È¤K®É¦Ü¤U¤È¤®É¡A¹O®É¤£¤©¿ì²z¡C
- ³ø¨ì¦aÂI¡G¥x¤jÂå°|°ê»Ú·|ij¤¤¤ß¤G¼Ó¤jÆU¦~·|³ø¨ì³B(¥x¥_¥«®}¦{¸ô2¸¹)¡C
BÃþ±Ð¨|¾Ç¤À¡G¤G³õÃB¥~»{©w¾Ç¤À¡A¨C³õBÃþ5¤À
Á|¿ì¤é´Á |
Á|¿ì®É¶¡ |
³ø¨ì¦aÂI |
ÃÙ§U¼t°Ó |
12¤ë5¤é
¡]¬P´Á¤»¡^ |
12:10 PM ~ 13:20 PM |
301Á¿°óªù¤f |
¥xÆW¦ÊÆF¨Î®ï®æ¿« (ªÑ)¤½¥q |
¥DÃD¡GComprehensive glycemic control |
12¤ë6¤é
¡]¬P´Á¤é¡^ |
12:10 PM ~ 13:20 PM |
301Á¿°óªù¤f |
¬ü°ÓÀq¨FªFÃļt(ªÑ)¤½¥q¥xÆW¤À¤½¥q |
¥DÃD¡GClinical implications of cardiovascular safety trial with DPP-4is in managing T2DM |
CÃþ¾Ç¤À¡GÁ|¿ì¤T³õ¡A·P±±¡BÂåÀøªk³W¡B¨â©ÊijÃD¾Ç¤À¥Ó½Ð¤¤¡C
- ³ø¨ì¤è¦¡¡G¬°ÁYµu³ø¨ì®É¶¡¡A½Ð·|û«ù¡u¨¥÷ÃÒ¡v³q¹L¡u±ø½X¾÷¡vŪ¨ú±ø½X»{©w¾Ç¤À¡C
- ³ø¨ì¦aÂI¡G¥x¤jÂå°|°ê»Ú·|ij¤¤¤ß402Á¿°óªù¤f¡C
- ¾Ç¤Àpºâ¡G¨Ì³ø¨ì®É¶¡¨ê¥d¡A¨Ã©ó¨ê°h®É¶¡¨ê¥d¡A¥i¥H¨ú±oCÃþ¾Ç¤À¡C¶È¤@¦¸¨ê¥d³ø¨ì©Î¨ê¥dÂ÷³õ¡A¨ä¾Ç¤À¤@«ß¤£¤©pºâ¡C
Á|¿ì¤é´Á |
Á|¿ì®É¶¡ |
¨ê¨ì®É¶¡ |
¨ê°h®É¶¡ |
12¤ë6¤é
¡]¬P´Á¤é¡^ |
10:20 AM ~ 12:00 PM |
10:05 AM ~ 10:35 AM |
11:45 AM~ 12:15 PM |
¥ìªi©Ô»PMERS¡G°Êª«»P¤HÃþ·P¬V¯g
Ebola and MERS: Human infections from animal sources
¡i±i¤W²E¡B¶¾ªø·¡j |
12¤ë6¤é
¡]¬P´Á¤é¡^ |
1:30 PM ~ 3:10 PM |
1:15 PM ~ 1:45 PM |
2:45 PM ~ 3:15 PM |
¯f±w¦w¥þ»PÂåÀø«~½è¡i¬x«a¤©¡j |
12¤ë6¤é
¡]¬P´Á¤é¡^ |
3:20 PM ~ 5:00 PM |
3:05 PM ~ 3:35 PM |
4:45 PM~ 5:15 PM |
§ÜÃĩʲӵ߻P§Ü·L¥Íª«»s¾¯ºÞ²z
Combating antimicrobial resistant bacteria and Antimicrobial stewardship program (ASP)¡i¤ý´_¼w¡BÁ§³Õ¤¯¡j |
¤º¬ì¦U²Ó±M¬ì¾Ç¤À¡G¥Ó½Ð»{©w¤¤¡C
®a®xÂå¾Ç·|¾Ç¤À¡G¥Ó½Ð»{©w¤¤¡C½Ð·|û«ù¡u¨¥÷ÃÒ¡vu¤@¼Ó¤jÆU¡u¤º¬ìÂå¾Ç·|ªA°È³B¡v³ø¨ì¡C¤G¤Ñ¾Ç¤À¦U§O»{©w¡B¦U§O³ø¨ì¡C
¿}§¿¯f¦@¦P·ÓÅ@ºô¾Ç¤À¡G¾Ç¤À¥Ó½Ð¤¤¡C
- Á|¿ì®É¶¡¡G12¤ë6¤é¡]¬P´Á¤é¡^10:20 AM ~ 12:00 PM
- ºtÁ¿ÃD¥Ø¡G¡u2015¿}§¿¯f·ÓÅ@«ü¤Þ¡v¡i³\´fùÚ¡B»pàæ¡j¡C
- ³ø¨ì¦aÂI¡G¥x¤jÂå°|°ê»Ú·|ij¤¤¤ß401Á¿°óªù¤f¡C
¦~·|¿n¤À¤@Äýªí |